Skip to main content

By Biocat

HIVACAT, the Catalan program that has been working to develop a therapeutic and preventative HIV vaccine since 2006, is holding a seminar, open to the scientific community, to discuss the latest breakthroughs in curing this disease. The event will take place on 15 October at 6 pm at the CaixaForum in Barcelona, coinciding with the annual symposium New strategies for HIV vaccine development HIVACAT also is also holding (invitation only) in Barcelona.

The opening of the seminar will feature scientists Bonaventura Clotet and Josep M. Gatell, co-directors of HIVACAT. Afterwards, there will be two presentations from IrsiCaixa physicians/researchers with close links to this cutting-edge research on a global level: What is HIV and what is AIDS, from a scientific and historical viewpoint, by Dr. Pep Coll, and Vaccine research and other strategies to cure HIV, by Dr. Beatriz Mothe. The session will finish with a conference entitled Educational programs to raise awareness of HIV/AIDS research by Rosina Malagrida, head of Science Communication at IrsiCaixa.

Program and registration

The HIVACAT program is managed by a public/private consortia that is unprecedented in Spain, made up of the IrsiCaixa AIDS Research Institute and the Hospital Clínic Barcelona-IDIBAPS Infectious Disease and AIDS Unit, in coordination with Esteve, the “la Caixa” Foundation and the Government of Catalonia departments of Health and of the Economy and Knowledge. 

Date: 15 October 2012
Time: 6 to 8 pm
Place: CaixaForum Barcelona • Sala1 • Av. Francesc Ferrer i Guàrdia, 6-8 • Barcelona

On this topic, we recommend the interview Biocat published in November 2011 with Dr. Josep M. Gatell: "The formula we’ve used has yielded scientific, economic and image-related results".

In 2011, HIVACAT and B·Debate (then known as the International Center for Scientific Debate) organized the 8th International Retroviral NC Symposium in Barcelona to study new ways to fight AIDS and the flu.

Sign up for our newsletters

Stay up-to-date on the latest news, events and trends in the BioRegion.